If you are having trouble viewing this email, please view it on our website.

         
 
A Service Announcement from Pharmexec
  Pharmexec logo  
     
   
 
Vantage

EP Vantage podcasts
Register for a free trial

Download these recent podcasts from EP Vantage and if you enjoy them then register for a four week free trial. EP Vantage is powered by EvaluatePharma® and offers incisive daily analysis of the pharma and biotech sector, putting the latest market developments into commercial context.

Free EP Vantage

Written for pharma and finance professionals, EP Vantage has unique access to proprietary analysis from EvaluatePharma®, giving readers insights other sources just can't match.

 

Follow the links below to download these podcasts of recent analysis:

Drug prices rise in anticipation of reform and patent cliff
BIO 2010 - Biosimilar pathway cleared in US but will any company set foot on it?
Humira set to steal Avastin's crown
Pfizer clinging on to top spot in 2016

If you no longer wish to receive emails from EvaluatePharma, please reply to mailings@evaluatepharma.com with "unsubscribe" in the subject line.

EvaluatePharma Ltd. 11- 29 Fashion St. London E1 6PX UK  www.evaluatepharma.com
 

 

Pharmaceutical Executive is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ 08830.
This is an advertisement sent on behalf of this advertiser.